Non-alcoholic Fatty Liver Disease: all 1,507 studies
Page 3 of 16. Open to participants first (303), then studies with results posted, then the rest; newest registration first within each.
- Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic SteatohepatitisRecruitingNCT05821010Phase 2
- Lifestyle Modification in the Treatment of NAFLD.RecruitingNCT05816915Not applicable
- NAFLD in Patient of HypothyroidismNot yet recruitingNCT05813301
- Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes MellitusRecruitingNCT05779644Not applicable
- Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLDRecruitingNCT05766449
- Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 AnalogueRecruitingNCT05751720Phase 1/2
- Clinical Study of SARS-CoV-2 Vaccine in Metabolism-related Fatty Liver DiseaseNot yet recruitingNCT05738707
- Using Hydroxychloroquine to Treat Nonalcoholic SteatohepatitisRecruitingNCT05733897
- Comparative Clinical Study to Evaluate the Efficacy and Safety of Rosuvastatin Vs CoQ10 on Nonalcoholic SteatohepatitisNot yet recruitingNCT05731596Phase 3
- Endoscopic Ultrasound Shear Wave Elastography in Patients With Non-alcoholic Fatty Liver DiseaseRecruitingNCT05728697
- Predicting Outcomes in Nonalcoholic Steatohepatitis With Advanced FibrosisRecruitingNCT05720663
- Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic PatientsRecruitingNCT05699018Not applicable
- Non-Alcoholic Fatty Liver Disease in a Saudi Cohort With Type 2 Diabetes MellitusRecruitingNCT05697991
- CT Liver Fat Fraction QuantificationEnrolling by invitationNCT05676177Not applicable
- Nutraceutical Improvement of Glucose Metabolism, NAFLD and Insulin Resistance by Oat-fiber Supplementation in Type 2 Diabetes Mellitus PatientsRecruitingNCT05654805Not applicable
- A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)RecruitingNCT05648214Phase 1/2
- HuHuangLianzonggan Capsule in Subjects With Nonalcoholic Steatohepatitis: a Phase 2 tRial(HHL-HEPAR)RecruitingNCT05632861Phase 2
- Observational Study About Patients Diagnosed With NAFLDRecruitingNCT05625750
- CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic SyndromeRecruitingNCT05623150
- Evaluate the Efficacy, Safety and Tolerability of Fecal Microbiota Transfer for the Treatment of Patients With Nonalcoholic SteatohepatitisNot yet recruitingNCT05622526Phase 2
- Prevention of NAFLD and CVD Through Lifestyle InterventionRecruitingNCT05618626Not applicable
- Prevalence of MAFLD in Patients With Type 2 Diabetes in Jiangsu Province of ChinaRecruitingNCT05597709
- Cognitive Assessment and Brain Function Evaluation in Patients With Non-alcoholic Fatty Liver DiseaseEnrolling by invitationNCT05563259
- Metabolic Subtypes of Non-Alcoholic Fatty Liver DiseaseRecruitingNCT05560997
- The Effect of Bariatric Surgery on Hepatic Metabolism in Non-Alcoholic Fatty Liver DiseaseEnrolling by invitationNCT05551559Not applicable
- BeijngFH Health Cohort StudyRecruitingNCT05546086
- Fructose and Liver Diseases in Youth: Help Them FLYRecruitingNCT05528471Not applicable
- Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in VeteransRecruitingNCT05526144Phase 2
- A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This ConditionRecruitingNCT05519475Phase 2
- Gastric Bypass Stent Small-Sample-Size Study For Nonalcoholic Fatty Liver DiseaseRecruitingNCT05495139Not applicable
- Soluble Fibre Supplementation in NAFLDRecruitingNCT05480696Phase 2
- Evaluation of Gut Permeability in Patients Affected by Obesity and NAFLD: Influence of Ketogenic Diet.RecruitingNCT05477212Not applicable
- InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for CancerRecruitingNCT05463796
- Beneficial Effects of Dietary and Lifestyle Change in Overweight and Obese SubjectsNot yet recruitingNCT05447351
- Metabolic Pathology of Pediatric NAFLDRecruitingNCT05430178Not applicable
- Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver TransplantRecruitingNCT05424003Phase 2
- Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver DiseaseRecruitingNCT05332613Not applicable
- Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver DiseaseRecruitingNCT05330923
- Comparison Between the Efficacy of Residential and Ambulatory Weight Loss Programs for Pediatric Non-alcoholic Fatty Liver DiseaseRecruitingNCT05309863
- Quantifying Hepatic Mitochondrial Fluxes in HumansRecruitingNCT05305287Phase 4
- Gut Permeability and Bariatric-metabolic SurgeryRecruitingNCT05257200
- A Prospective/Retrospective, Observational Follow-up Study of Chronic Hepatitis B With Non-alcoholic Fatty Liver Disease.RecruitingNCT05255978
- Impact of Time-restricted Feeding in NAFLDRecruitingNCT05220956Not applicable
- Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin ResistanceRecruitingNCT05165706Not applicable
- Norursodeoxycholic Acid vs. Placebo in NASHRecruitingNCT05083390Phase 2
- Metabolic Phenotyping and Follow-Up of Patients With and Without Diabetes After New Onset of STEMIRecruitingNCT05046483
- Clinical Outcomes From Enhanced SCREENing Strategies for NASH in Type 2 Diabetes (SCREEN NASH T2D)RecruitingNCT05029583Not applicable
- Impact of Cold Exposure on Metabolic Regulation in Children With Non Alcoholic Fatty Liver Disease (NAFLD)RecruitingNCT04969744Not applicable
- THE FRENCH NATIONAL NAFLD COHORT (FRench pAtients With MEtabolic Steatosis)Not yet recruitingNCT04925362Not applicable
- NAFLD Primary CareRecruitingNCT04918732Not applicable
- Intermittent Fasting for NAFLD in AdultsRecruitingNCT04899102Not applicable
- Biometabolic Outcomes After Weight Loss Surgery: An Individualized ApproachEnrolling by invitationNCT04841057Not applicable
- AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)RecruitingNCT04807868
- Interest in "Combo" (a Combination of Dietary Supplements Including Probiotics) in NASH ImprovementRecruitingNCT04781933Not applicable
- Role of Regulatory B Cells in the Pathogenesis of Metabolic Associated Fatty Liver DiseaseRecruitingNCT04720560
- Namodenoson in the Treatment of Non-Alcoholic Steatohepatitis (NASH)RecruitingNCT04697810Phase 2
- "Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".RecruitingNCT04690972
- Comparison of Two sTRAtegies For the Non-Invasive Diagnosis of advanCed Liver Fibrosis in NAFLDRecruitingNCT04681573Not applicable
- Integrated Diagnostics for Early Diagnosis of Liver DiseaseRecruitingNCT04666402
- Prevalence, Incidence and Characteristics of NAFLD/NASH in Type 1 Diabetes MellitusRecruitingNCT04664036
- Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)RecruitingNCT04634643
- A Prospective Cohort Study of Metabolic Associated Fatty Liver Disease in ChinaRecruitingNCT04573283
- Multicenter Registry of Nonalcoholic Fatty Liver DiseaseNot yet recruitingNCT04540731
- Liver Disease and Other Systemic DiseasesRecruitingNCT04525833
- Low-Dose Pioglitazone in Patients With NASH (AIM 2)RecruitingNCT04501406Phase 2
- The Evaluation of Orange Peel Fermentation on Body Fat Lowering Efficacy in AdultsRecruitingNCT04496895Not applicable
- The European NAFLD RegistryRecruitingNCT04442334
- PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic StudiesRecruitingNCT04371042
- The Olmsted NAFLD Epidemiology Study (TONES)RecruitingNCT04365855Not applicable
- Fatty Liver Disease in Nordic CountriesRecruitingNCT04340817
- Investigating the Link Between Type 2 Immunity and NAFLD in Human ObesityRecruitingNCT04232566
- Genetic Pathways Leading to Fatty Liver and Atherogenic DyslipidemiaEnrolling by invitationNCT04209816
- European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD)RecruitingNCT04190849
- Investigating Pathological Mechanisms in Non-alcoholic Fatty Liver DiseaseRecruitingNCT04141592
- the Role of plin5 in the Development of Nonalcoholic Fatty Liver Disease.RecruitingNCT04104282
- Non-Invasive Quantification of Liver Health in NASH (N-QUAN)RecruitingNCT04054310Not applicable
- Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)RecruitingNCT03884075Phase 2
- Change of Adipose Tissues and Triglyceride After Bariatric Surgery or Life-style InterventionRecruitingNCT03875625Not applicable
- SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver DiseaseNot yet recruitingNCT03867487Phase 2
- Cold-induced Brown Fat Activation and Hepatic SteatosisRecruitingNCT03811236Not applicable
- Dynamic Changes and Risk Factors of Fibrosis and Steatosis Progression in Nonalcoholic Fatty Liver DiseaseRecruitingNCT03635541
- Quantitative Ultrasound Techniques for Diagnosis of Nonalcoholic SteatohepatitisRecruitingNCT03572465
- Prognostic Significance of Fatty Liver Disease in Bariatric PatientsRecruitingNCT03535142Not applicable
- Screening With FibroTouch for Advanced Liver Fibrosis in NAFLD Patients With Underlying Type 2 DiabetesRecruitingNCT03525769
- A Randomized Controlled Study Evaluating Bariatric Surgery as a Treatment for Severe NASH With Advanced Liver Fibrosis in Non-severe Obese PatientsRecruitingNCT03472157Not applicable
- A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of SNP-610 for the Treatment of Patients With Non-alcoholic SteatohepatitisNot yet recruitingNCT03468556Phase 2
- Disease Prevention in Clinical Practice Base on Patient Specific PhysiologyEnrolling by invitationNCT03308773
- Great China Fatter Liver Consortium (GC_FLC) Study to Assess the Progress of NAFLD/NASH in ChineseNot yet recruitingNCT03282305
- Nonalcoholic Steatohepatitis in Chinese ChildrenRecruitingNCT03190538
- Longitudinal Observational Study Of Chinese With NAFLD/NASHRecruitingNCT03151473
- A Prospective, Randomized, Open Label Trial of Two Doses of Oral BetaineRecruitingNCT03073343Not applicable
- Blood Collection Biorepository for Liver Disease ResearchRecruitingNCT03025074
- Bariatric Embolization of Arteries for the Treatment of Nonalcoholic SteatohepatitisNot yet recruitingNCT02933554Not applicable
- Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver DiseaseRecruitingNCT02863757
- Epigenetic Mechanisms and Severe Obesity (Biological Tissue Collection)RecruitingNCT02663388
- Low Calorie Diet and DiabetesEnrolling by invitationNCT02498990Not applicable
- Prospective Cohort, With Biobanking, of Patients With Nonalcoholic Fatty Liver DiseaseRecruitingNCT02422238
- Fatty Liver Patient RegistryRecruitingNCT02298439
- Reversal of Lipid-Induced Insulin ResistanceRecruitingNCT02193295Not applicable
- The Influence of Autophagy on Fatty LiverRecruitingNCT01988441